Early-onset breast cancer in a woman with Graves' disease

被引：0
|
作者：
Siegler, James E. [1 ]
Li, Xinying [2 ]
Jones, Steven D. [3 ]
Kandil, Emad [4 ]
机构：
[1] Tulane Univ, Sch Med, New Orleans, LA 70112 USA
[2] Cent S Univ, Xiangya Hosp, Dept Gen Surg, Changsha, Hunan, Peoples R China
[3] Tulane Sch Med, Dept Surg, New Orleans, LA USA
[4] Tulane Univ, Sch Med, Dept Surg, Div Endocrine & Oncol Surg, New Orleans, LA 70112 USA
来源：
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE | 2012年 / 5卷 / 04期
关键词：
Graves' disease; thyroid hormone; estrogen; breast cancer; THYROID-HORMONE; ESTROGEN;
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
The relationship between thyroid and breast diseases has been documented, but the clinical significance of Graves' disease and breast cancer is unclear. We present a young patient with a history of Graves' disease who developed a multicentric infiltrating ductal carcinoma of the breast several months after discontinuing her treatment with propylthiouracil. Early-onset breast cancer in women without a family history of early breast cancer may be related to hyperthyroidism. The relationship between thyroid hormone and estrogen is discussed.
引用
收藏
页码：358 / 362
页数：5
相关论文
共 50 条
  • [41] Familial association of laryngeal, lung, stomach and early-onset breast cancer
    Ewa Jaworowska
    Pablo Serrano-Fernández
    Czesława Tarnowska
    Jakub Lubiński
    Marek Brzosko
    Jacek Flicinski
    Bartołomej Masojc
    Joanna Matyjasik
    Rodney J. Scott
    Steven A. Narod
    Jan Lubiński
    Breast Cancer Research and Treatment, 2008, 112 : 359 - 361
  • [42] Characteristics and therapy of premenopausal patients with early-onset breast cancer in Germany
    Constanze Banz-Jansen
    Alessa Heinrichs
    Marianne Hedderich
    Annika Waldmann
    Christine Dittmer
    Berit Wedel
    Imke Mebes
    Klaus Diedrich
    Dorothea Fischer
    Archives of Gynecology and Obstetrics, 2012, 286 : 489 - 493
  • [43] Constitutional alterations of the ATM gene in early-onset sporadic breast cancer
    P Maillet
    H Bonnefoi
    A-P Sappino
    Breast Cancer Research, 2 (Suppl 1)
  • [44] ABSENCE OF GERMLINE PROHIBITIN MUTATIONS IN EARLY-ONSET BREAST-CANCER
    TOKINO, T
    DAVIDSON, N
    HELZLSOUER, K
    ZEHNBAUER, B
    NAKAMURA, Y
    VOGELSTEIN, B
    SIDRANSKY, D
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1993, 3 (04) : 769 - 772
  • [45] BRCA-1 mutations in early-onset breast cancer.
    Márquez, A
    Alba, E
    Ribelles, N
    Sevilla, I
    Rueda, A
    Alonso, L
    Mons, E
    Trujillo, R
    Cobo, M
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S57 - S57
  • [46] Familial association of laryngeal, lung, stomach and early-onset breast cancer
    Jaworowska, Ewa
    Serrano-Fernandez, Pablo
    Tarnowska, Czeslawa
    Lubinski, Jakub
    Brzosko, Marek
    Flicinski, Jacek
    Masojc, Bartolomej
    Matyjasik, Joanna
    Scott, Rodney J.
    Narod, Steven A.
    Lubinski, Jan
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 112 (02) : 359 - 361
  • [47] Quality of care for premenopausal patients with early-onset breast cancer in Germany
    Fischer, D.
    Hedderich, M.
    Heinrich, A.
    Wedel, B.
    Banz-Jansen, C.
    Rody, A.
    Waldmann, A.
    CANCER RESEARCH, 2013, 73
  • [48] Executive Summary of the Early-Onset Breast Cancer Evidence Review Conference
    Chelmow, David
    Pearlman, Mark D.
    Young, Amy
    Bozzuto, Laura
    Dayaratna, Sandra
    Jeudy, Myrlene
    Kremer, Mallory E.
    Scott, Dana Marie
    O'Hara, Julia Sage
    OBSTETRICS AND GYNECOLOGY, 2020, 135 (06): : 1457 - 1478
  • [49] Novel gene predicts local recurrence in early-onset breast cancer
    不详
    CANCER BIOLOGY & THERAPY, 2009, 8 (10) : IV - IV
  • [50] Incidence trends of early-onset breast cancer by lifestyle risk factors
    Rantala, Jasmiina
    Seppa, Karri
    Eriksson, Johan
    Heinavaara, Sirpa
    Harkanen, Tommi
    Jousilahti, Pekka
    Knekt, Paul
    Mannisto, Satu
    Rahkonen, Ossi
    Malila, Nea
    Makinen, Eetu
    Ryynaenen, Heidi
    Laaksonen, Maarit
    Heikkinen, Sanna
    Pitkaniemi, Janne
    METCA Study Grp
    BMC CANCER, 2025, 25 (01)
12345